Luis Cabezón-Gutiérrez

7PUBLICATIONS
20CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 19, 2026
Current patterns of next-generation sequencing implementation in hepatocellular carcinoma in Spain.

|Apr 15, 2026
Prognostic and predictive biomarkers in thymic epithelial tumors: beyond traditional staging: a narrative review.

Luis Cabezón-Gutiérrez, Vilma Pacheco-Barcia, Sara Custodio-Cabello

|Nov 27, 2025
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).

Silvia Masini, Monica Antoñanzas Basa, Antonio Calles

|Mar 17, 2025
Metabolic mechanisms of immunotherapy resistance.

Luis Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio-Cabello

|Jun 17, 2024
Update on thymic epithelial tumors: a narrative review.

Luis Cabezón-Gutiérrez, Vilma Pacheco-Barcia, Fátima Carrasco-Valero

|May 19, 2023
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma.

Celia Lara-Morga, Magda Palka-Kotlowska, Sara Custodio-Cabello

Pageof 2

Frequent Collaborators

1 joint publications

María Sereno

1 joint publications

Magda Palka-Kotlowska

1 joint publications

Sara Custodio-Cabello

1 joint publications

Vilma Pacheco-Barcia